All Type of News
Wholesaling industry promises to clean house
The Korea Pharmaceutical Wholesaler Association has pledged to improve unethical business practices as wholesalers have handled almost 80 percent of the domestic drug logistics business in 2010, citing a report by a g...
Ilyang’s new leukemia drug shows promise
Ilyang Pharmaceutical Co. says it will carry out a Phase III clinical trial of radotinib, a new leukemia medicine.
The drug is believed to be 30 times more effective than Gleevec, a popular anti-leukemia medicine. ...
Rheumatoid arthritis market to get heated
Competition is about to heat up in the domestic rheumatoid arthritis market as Green Cross Corp. will also join the market by launching its newly developed natural drug “Shinbaro” from next month.
A 12-week study o...
Restrictive OTC drugs are sold at supermarkets
Many supermarkets are selling over-the-counter drugs that should be sold only in pharmacies, according to a recent survey of 120 retail outlet operators conducted by Incheon Pharmacists Association.
The survey note...
Drug price cuts to corner local drugmakers
Local pharmaceutical companies have been largely dependent on producing and marketing generic drugs instead of inventing new drugs.
However, a new wave of price cuts for drugs is speculated to be imminent in Korea...
Discount stores promote selling of OTC products
With customers’ response being extremely positive, major discount stores have actively promoted more over-the-counter (OTC) drugs after they were officially allowed to be sold outside pharmacies across the country sta...
Drugmakers oppose government’s drug price cut plan
The Korea Pharmaceutical Manufacturers Association said Wednesday that it has vehemently opposed to the government’s another price cuts for generic drugs.
In a board of directors meeting, the association said that ...
Dong-A and Shanghai Zhongxi Sunve sign license agreement for Zydena
Dong-A Pharmaceutical Co. said Tuesday that it has signed an agreement with Shanghai Zhongxi Sunve Pharmaceutical Co. based in China to market Dong-A’s orally-administered udenafil product, a phosphodiesterase type 5 ...
Pharmaceutical stocks plunge on U.S. credit downgrade
Domestic drug firms have seen their stocks plummet over the past several days as retail and foreign investors have dumped shares on the U.S. credit downgrade and fears of a global economic recession.
The benchmark ...
Concerns rise among Korean drug makers
The domestic pharmaceutical sector is expected to face an inevitable blow with major drug companies from the United States taking a stronger hold of the local market following if a U.S.-Korea free trade agreement goes...
